Generex touts positive AE37 cancer vaccine technology
by on Saturday, June 9th, 2012 | No Comments
Generex Biotechnology reported promising technology and clinical results from its on-going phase II trial of the AE37 breast cancer vaccine being developed by its subsidiary Antigen Express.
Continued here: Generex touts positive AE37 cancer vaccine technology